IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Anti-Proliferative Efficacy of Icariin on HepG2 Hepatoma and Its Possible Mechanism of Action
Yang, Jin-Xia1,2; Fichtner, Iduna3; Becker, Monika3; Lemm, Margit3; Wang, Xue-Mei1,2
关键词Icariin Hepg2 Cd31 Ki67 Flow Cytometry Mtt Assay Immunohistochemical Assay
刊名AMERICAN JOURNAL OF CHINESE MEDICINE
2009
DOI10.1142/S0192415X09007569
37期:6页:1153-1165
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Integrative & Complementary Medicine ; Medicine, General & Internal
研究领域[WOS]Integrative & Complementary Medicine ; General & Internal Medicine
关键词[WOS]HEPATOCELLULAR-CARCINOMA ; ENDOTHELIAL-CELLS ; IN-VITRO ; DIFFERENTIATION ; ANGIOGENESIS ; EXPRESSION ; GLYCOSIDES ; GROWTH ; TUMORS ; RATS
英文摘要

The aim of the present work was to explore the anti-hepatoma effects of icariin both in vitro and in vivo and to elucidate its potential mechanism of action. The MTT assay was applied to test the anti-proliferative effects of icariin in vitro. HepG2 bearing NMRI nu/nu mice were used to test the anticancer effects of icariin in vivo. Immunohistochemical assay and flow cytometry assay (FACS) were applied to detect the possible mechanisms of action of icariin. MTT assay illustrated that icariin inhibited the proliferation of HepG2 cells in a concentration dependent manner; meanwhile, icariin inhibited the tumor growth in HepG2 bearing NMRI nu/nu mice. The tumor weight was inhibited by 55.6% and tumor volume was inhibited by 47.2%. Icariin did not influence the spleen and body weights or blood parameters. Immunohistochemical analysis indicated that the expressions of both CD31 and Ki67 in the icariin treated group were significantly lower than those in the control group (p < 0.01). FACS assay showed that icariin dramatically decreased the percentage of CD4+ and CD8+ cells in bone marrow and CD19+ cells in blood on day 8. On day 17, the percentage of CD8+ cells in blood was lower than those in the control group. CD4/CD8 ratio in icariin group was significantly elevated in bone marrow on day 17. Icariin showed anticancer efficacy both in vitro and in vivo. The possible mechanism of action could be related to its anti-angiogenesis and anti-proliferative effects in tumors.

语种英语
WOS记录号WOS:000272093600012
引用统计
被引频次:19[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/53767
专题北京大学第一临床医学院
作者单位1.Peking Univ, Hosp 1, Integrated Lab TCM & Western Med, Beijing 100034, Peoples R China
2.Peking Univ, Integrated Inst TCM & Western Med, Beijing 100034, Peoples R China
3.Expt Pharmacol Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
推荐引用方式
GB/T 7714
Yang, Jin-Xia,Fichtner, Iduna,Becker, Monika,et al. Anti-Proliferative Efficacy of Icariin on HepG2 Hepatoma and Its Possible Mechanism of Action[J]. AMERICAN JOURNAL OF CHINESE MEDICINE,2009,37(6):1153-1165.
APA Yang, Jin-Xia,Fichtner, Iduna,Becker, Monika,Lemm, Margit,&Wang, Xue-Mei.(2009).Anti-Proliferative Efficacy of Icariin on HepG2 Hepatoma and Its Possible Mechanism of Action.AMERICAN JOURNAL OF CHINESE MEDICINE,37(6),1153-1165.
MLA Yang, Jin-Xia,et al."Anti-Proliferative Efficacy of Icariin on HepG2 Hepatoma and Its Possible Mechanism of Action".AMERICAN JOURNAL OF CHINESE MEDICINE 37.6(2009):1153-1165.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yang, Jin-Xia]的文章
[Fichtner, Iduna]的文章
[Becker, Monika]的文章
百度学术
百度学术中相似的文章
[Yang, Jin-Xia]的文章
[Fichtner, Iduna]的文章
[Becker, Monika]的文章
必应学术
必应学术中相似的文章
[Yang, Jin-Xia]的文章
[Fichtner, Iduna]的文章
[Becker, Monika]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。